Ensysce Biosciences (ENSC) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 3, 2023 (06:23)
Sector: HealthcareThe share price of Ensysce Biosciences, Inc. (ENSC) now
50/200 Day Moving Average: $1.165 / $2.9
This figure corresponds to the Average Price over the previous 50/200 days. For Ensysce Biosciences stocks, the 50-day moving average is the resistance level today.
For Ensysce Biosciences stocks, the 200-day moving average is the resistance level today.
Are you interested in Ensysce Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Ensysce Biosciences stock price in 2023, 2024, 2025, 2026, 2027. How much will one Ensysce Biosciences share be worth in 2023 - 2027?
When should I take profit in Ensysce Biosciences stock? When should I record a loss on Ensysce Biosciences stock? What are analysts' forecasts for Ensysce Biosciences stock? What is the future of Ensysce Biosciences stock? We forecast Ensysce Biosciences stock performance using neural networks based on historical data on Ensysce Biosciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Ensysce Biosciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Ensysce Biosciences shares. This happens once a day.
Historical and forecast chart of Ensysce Biosciences stock
The chart below shows the historical price of Ensysce Biosciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Ensysce Biosciences stock price can be found in the table below.
Long-term forecasts by years.
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on proprietary technology platforms to develop safer prescription drugs. The firm’s Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms, are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company is headquartered in La Jolla, CA.
Ensysce Biosciences daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 05 | 0.97 | 0.87 | 1.07 | 22.14 |
| Dec 06 | 0.94 | 0.90 | 1.01 | 11.43 |
| Dec 07 | 0.95 | 0.88 | 1.03 | 18.03 |
| Dec 08 | 0.96 | 0.87 | 1.07 | 22.47 |
| Dec 09 | 0.94 | 0.89 | 1.01 | 12.47 |
| Dec 10 | 1.04 | 0.92 | 1.10 | 19.84 |
| Dec 11 | 0.97 | 0.88 | 1.02 | 15.66 |
| Dec 12 | 0.96 | 0.90 | 1.01 | 12.83 |
| Dec 13 | 0.84 | 0.79 | 0.91 | 15.64 |
| Dec 14 | 0.75 | 0.68 | 0.78 | 15.55 |
| Dec 15 | 0.71 | 0.64 | 0.77 | 20.88 |
| Dec 16 | 0.78 | 0.69 | 0.87 | 26.24 |
| Dec 17 | 0.85 | 0.79 | 0.90 | 13.99 |
| Dec 18 | 0.93 | 0.89 | 0.97 | 9.27 |
| Dec 19 | 0.99 | 0.87 | 1.06 | 22.29 |
| Dec 20 | 1.13 | 1.02 | 1.18 | 15.96 |
| Dec 21 | 1.06 | 1.00 | 1.15 | 15.02 |
| Dec 22 | 1.03 | 0.93 | 1.14 | 21.72 |
| Dec 23 | 1.10 | 1.04 | 1.14 | 9.20 |
| Dec 24 | 1.06 | 0.97 | 1.14 | 17.11 |
| Dec 25 | 1.04 | 0.93 | 1.08 | 16.51 |
| Dec 26 | 1.11 | 1.07 | 1.25 | 16.18 |
| Dec 27 | 1.23 | 1.15 | 1.37 | 19.66 |
| Dec 28 | 1.31 | 1.22 | 1.44 | 18.59 |
| Dec 29 | 1.37 | 1.33 | 1.47 | 11.19 |
| Dec 30 | 1.48 | 1.34 | 1.60 | 19.55 |
| Dec 31 | 1.27 | 1.21 | 1.33 | 9.93 |
| Jan 01 | 1.18 | 1.09 | 1.23 | 12.81 |
| Jan 02 | 1.14 | 1.06 | 1.20 | 13.74 |
| Jan 03 | 1.17 | 1.10 | 1.26 | 14.68 |
Ensysce Biosciences Daily Price Targets
Ensysce Biosciences Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $0.97.
Positive dynamics for Ensysce Biosciences shares will prevail with possible volatility of 18.128%.
Pessimistic target level: 0.87
Optimistic target level: 1.07
Ensysce Biosciences Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $0.94.
Negative dynamics for Ensysce Biosciences shares will prevail with possible volatility of 10.257%.
Pessimistic target level: 0.90
Optimistic target level: 1.01
Ensysce Biosciences Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $0.95.
Positive dynamics for Ensysce Biosciences shares will prevail with possible volatility of 15.275%.
Pessimistic target level: 0.88
Optimistic target level: 1.03
Ensysce Biosciences Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $0.96.
Positive dynamics for Ensysce Biosciences shares will prevail with possible volatility of 18.348%.
Pessimistic target level: 0.87
Optimistic target level: 1.07
Ensysce Biosciences Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $0.94.
Negative dynamics for Ensysce Biosciences shares will prevail with possible volatility of 11.085%.
Pessimistic target level: 0.89
Optimistic target level: 1.01
Ensysce Biosciences Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $1.04.
Positive dynamics for Ensysce Biosciences shares will prevail with possible volatility of 16.557%.
Pessimistic target level: 0.92
Optimistic target level: 1.10
ENSC (ENSC) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec. | 0.75 | 0.67 | 0.91 | 26.03 |
Ensysce Biosciences forecast for this year
Ensysce Biosciences Stock Prediction for Dec 2023
An downtrend is forecast for this month with an optimal target price of $0.750508. Pessimistic: $0.67. Optimistic: $0.91
Ensysce Biosciences (ENSC) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.94 | 0.82 | 1.09 | 24.78 |
| Mar | 1.01 | 0.89 | 1.21 | 26.29 |
| Mar | 1.03 | 0.81 | 1.27 | 36.47 |
| Apr | 1.10 | 0.90 | 1.33 | 32.56 |
| May | 1.21 | 1.04 | 1.49 | 30.39 |
| Jun | 1.57 | 1.33 | 1.75 | 23.76 |
| Jul | 1.79 | 1.47 | 2.09 | 29.87 |
| Aug | 1.55 | 1.21 | 1.74 | 30.54 |
| Sep | 1.09 | 0.98 | 1.35 | 27.34 |
| Oct | 1.01 | 0.91 | 1.14 | 20.46 |
| Nov | 1.02 | 0.79 | 1.25 | 36.64 |
| Dec | 1.30 | 1.13 | 1.54 | 26.70 |
Ensysce Biosciences (ENSC) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.57 | 1.22 | 1.82 | 33.05 |
| Mar | 1.96 | 1.71 | 2.23 | 23.66 |
| Mar | 2.16 | 1.72 | 2.35 | 26.70 |
| Apr | 2.22 | 1.98 | 2.68 | 26.03 |
| May | 2.86 | 2.59 | 3.14 | 17.47 |
| Jun | 2.83 | 2.54 | 3.40 | 25.42 |
| Jul | 2.04 | 1.77 | 2.21 | 20.15 |
| Aug | 1.59 | 1.22 | 1.85 | 33.73 |
| Sep | 1.54 | 1.33 | 1.71 | 22.14 |
| Oct | 1.57 | 1.24 | 1.70 | 26.99 |
| Nov | 1.63 | 1.44 | 1.79 | 19.71 |
| Dec | 1.62 | 1.41 | 1.87 | 24.91 |
Ensysce Biosciences (ENSC) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.07 | 1.65 | 2.42 | 31.59 |
| Mar | 2.19 | 2.00 | 2.63 | 23.79 |
| Mar | 2.44 | 1.93 | 2.90 | 33.31 |
| Apr | 2.25 | 2.02 | 2.61 | 22.78 |
| May | 2.52 | 2.27 | 2.83 | 19.55 |
| Jun | 2.15 | 1.93 | 2.34 | 17.39 |
| Jul | 2.34 | 2.00 | 2.85 | 29.61 |
| Aug | 2.21 | 1.93 | 2.54 | 24.06 |
| Sep | 2.51 | 1.91 | 2.69 | 28.91 |
| Oct | 3.00 | 2.38 | 3.45 | 31.22 |
| Nov | 2.55 | 2.15 | 2.87 | 25.24 |
| Dec | 3.05 | 2.39 | 3.30 | 27.47 |
Ensysce Biosciences (ENSC) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 3.73 | 3.49 | 3.96 | 11.85 |
| Mar | 3.30 | 3.05 | 3.89 | 21.67 |
| Mar | 2.32 | 1.81 | 2.54 | 28.74 |
| Apr | 1.70 | 1.49 | 2.07 | 28.30 |
| May | 1.73 | 1.60 | 1.97 | 18.72 |
| Jun | 1.78 | 1.38 | 2.14 | 35.72 |
| Jul | 1.91 | 1.77 | 2.19 | 19.09 |
| Aug | 2.03 | 1.55 | 2.32 | 33.13 |
| Sep | 2.47 | 2.03 | 2.64 | 23.08 |
| Oct | 2.25 | 2.02 | 2.48 | 18.51 |
| Nov | 2.30 | 1.89 | 2.50 | 24.56 |
| Dec | 2.89 | 2.34 | 3.57 | 34.52 |
Ensysce Biosciences information and performance
250 WEST 57TH ST., SUITE 415, NEW YORK, NY, US
Market capitalization of the Ensysce Biosciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ENSC shares in the company outstanding by the market price of one share.
EBITDA of Ensysce Biosciences is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
